Association of MICA gene Exon-5 polymorphism in oral submucous fibrosis

Published:September 07, 2022DOI:


      The present study was conducted to explore the allele frequencies of MICA gene Exon-5 transmembrane and to measure the circulatory MICA levels in various histologic grades of patients with oral submucous fibrosis (OSF) compared to healthy individuals.

      Study design

      We enrolled a total of 595 patients for this cross-sectional study and divided them into 2 groups: healthy controls (n = 320) and patients with OSF (n = 275). Further, patients with OSF were subdivided based on their histologic gradings. The genomic DNA was extracted followed by a polymerase chain reaction and genotyping using the ABI Prism DNA Sequencer (ThermoFisher Scientific, Inc., Waltham, MA, USA).


      Our study showed that the A5 allele of the MICA gene in the Exon-5 region conferred significant risk for patients with OSF. With reference to the histologic gradings of OSF, we found that the MICA gene conferred statistically significant risk among patients with grade III OSF. On the other hand, the A8 allele of MICA gene in the Exon-5 region conferred significant protection among the overall OSF cohort and in the grade III of histologic grade. Finally, the circulatory human MICA levels were found to have a stepwise increase from grade I toward grade III in patients with OSF.


      Our results suggested that the A5 allele in MICA might confer risk for the progression of OSF among the South Indian ethnic population.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


        • Shih YH
        • Wang TH
        • Shieh TM
        • Tseng YH.
        Oral submucous fibrosis: a review on etiopathogenesis, diagnosis, and therapy.
        Int J Mol Sci. 2019; 20: 2940
        • Peng Q
        • Li H
        • Chen J
        • Wang Y
        • Tang Z.
        Oral submucous fibrosis in Asian countries.
        J Oral Pathol Med. 2020; 49: 294-304
        • Tang JG
        • Jian XF
        • Gao ML
        • Ling TY
        • Zhang KH.
        Epidemiological survey of oral submucous fibrosis in Xiangtan City, Hunan Province, China.
        Community Dent Oral Epidemol. 1997; 25: 177-180
        • Shen YW
        • Shih YH
        • Fuh LJ
        • Shieh TM.
        Oral submucous fibrosis: a review on biomarkers, pathogenic mechanisms, and treatments.
        Int J Mol Sci. 2020; 21: 7231
        • Tilakaratne WM
        • Klinikowski MF
        • Saku T
        • Peters TJ
        • Warnakulasuriya S.
        Oral submucous fibrosis: review on aetiology and pathogenesis.
        Oral Oncol. 2006; 42: 561-568
        • Angadi PV
        • Rao SS.
        Areca nut in pathogenesis of oral submucous fibrosis: revisited.
        Oral Maxillofac Surg. 2011; 15: 1-9
        • Ali FM
        • Patil A
        • Patil K
        • Prasant MC.
        Oral submucous fibrosis and its dermatological relation.
        Indian Dermatol Online J. 2014; 5: 260-265
        • Cheng RH
        • Wang YP
        • Chang JY
        • Pan YH
        • Chang MC
        • Jeng JH.
        Genetic susceptibility and protein expression of extracellular matrix turnover-related genes in oral submucous fibrosis.
        Int J Mol Sci. 2020; 21: 8104
        • Canniff JP
        • Batchelor JR
        • Dodi IA
        • Harvey W.
        HLA-typing in oral submucous fibrosis.
        Tissue Antigens. 1985; 26: 138-142
        • Wichmann G
        • Herchenhahn C
        • Boehm A
        • et al.
        HLA traits linked to development of head and neck squamous cell carcinoma affect the progression-free survival of patients.
        Oral Oncol. 2017; 69: 115-127
        • Reinders J
        • Rozemuller EH
        • Otten HG
        • der Veken LT van
        • Slootweg PJ
        • Tilanus MG
        HLA and MICA associations with head and neck squamous cell carcinoma.
        Oral Oncol. 2007; 43: 232-240
        • López-Hernández R
        • Valdés M
        • Lucas D
        • et al.
        Association analysis of MICA gene polymorphism and MICA-129 dimorphism with inflammatory bowel disease susceptibility in a Spanish population.
        Human Immunol. 2010; 71: 512-514
        • Rueda B
        • Pascual M
        • López-Nevot MA
        • González E
        • Martín J
        A new allele within the transmembrane region of the human MICA gene with seven GCT repeats.
        Tissue Antigens. 2002; 60: 526-528
        • Pérez-Rodríguez M
        • Corell A
        • Argüello JR
        • et al.
        A new MICA allele with ten alanine residues in the exon 5 microsatellite.
        Tissue Antigens. 2000; 55: 162-165
        • Ding Y
        • Xia B
        • Lü M
        • et al.
        MHC class I chain-related gene A-A5.1 allele is associated with ulcerative colitis in Chinese population.
        Clin Exp Immunol. 2005; 142: 193-198
        • Yabuki K
        • Mizuki N
        • Ota M
        • et al.
        Association of MICA gene and HLA-B*5101 with Behcet's disease in Greece.
        Invest Ophthamol Vis Sci. 1999; 40: 1921-1926
        • Folwaczny M
        • Henninger M
        • Glas J.
        Impact of MICA-TM, MICB-C1_2_A and C1_4_1 microsatellite polymorphisms on the susceptibility to chronic periodontitis in Germany.
        Tissue Atigens. 2011; 77: 298-304
        • Liu CJ
        • Lee YJ
        • Chang KW
        • Shih YN
        • Liu HF
        • Dang CW.
        Polymorphism of the MICA gene and risk for oral submucous fibrosis.
        J Oral Pathol Med. 2004; 33: 1-6
        • Kimura A
        • Kobayashi Y
        • Takahashi M
        • et al.
        MICA gene polymorphism in Takayasu's arteritis and Buerger's disease.
        Int J Cardiol. 1998; 66 (discussion S115): S107-S113
        • Pindborg JJ
        • Sirsat SM.
        Oral submucous fibrosis.
        Oral Surg Oral Med Oral Pathol. 1966; 22: 764-779
        • Khanna JN
        • Andrade NN.
        Oral submucous fibrosis: a new concept in surgical management.
        Int J Oral Maxillofac Surg. 1995; 24 (Report of 100 cases): 433-439
        • Haider SM
        • Merchant AT
        • Fikree FF
        • Rahbar MH.
        Clinical and functional staging of oral submucous fibrosis.
        B J Oral Maxillofac Surg. 2000; 38: 12-15
        • Umapathy D
        • Krishnamoorthy E
        • Mariappanadar V
        • Viswanathan V
        • Ramkumar KM.
        Increased levels of circulating (TNF-ἁ-) is associated with (-308G/A) promoter polymorphism of TNF- ἁ gene in diabetic nephropathy.
        Int J Biol Macromol. 2018; 107: 2113-2121
        • Canniff JP
        • Harvey W
        • Harris M.
        Oral submucous fibrosis: its pathogenesis and management.
        B Dent J. 1986; 160: 429-434
        • Bravo MJ
        • Colmenero JD
        • Martín J
        • Alonso A
        • Caballero A.
        Polymorphism of the transmembrane region of the MICA gene and human brucellosis.
        Tissue Antigens. 2007; 69: 358-360
        • Kuo HC
        • Li SC
        • Guo MM
        • et al.
        Genome-wide association study identifies novel susceptibility genes associated with coronary artery aneurysm formation in Kawasaki disease.
        PloS One. 2016; 11e0154943
        • Ji M
        • Wang J
        • Yuan L
        • et al.
        MICA polymorphisms and cancer risk: a meta-analysis.
        Int J Clin Exp Med. 2015; 8: 818-826
        • Luo QZ
        • Lin L
        • Gong Z
        • et al.
        Positive association of major histocompatibility complex class I chain-related gene A polymorphism with leukemia susceptibility in the people of Han nationality of Southern China.
        Tissue Antigens. 2011; 78: 178-184
        • Mariaselvam CM
        • Boukouaci W
        • Charron D
        • et al.
        Association of MICA-129 polymorphism and circulating soluble MICA level with rheumatoid arthritis in a south Indian Tamil population.
        Int J Rheum Dis. 2018; 21: 656-663
        • Onyeaghala G
        • Nelson HH
        • Thyagarajan B
        • et al.
        Soluble MICA is elevated in pancreatic cancer: results from a population based case-control study.
        Mol Carcinog. 2017; 56: 2158-2164
        • Dambrauskas Z
        • Svensson H
        • Joshi M
        • Hyltander A
        • Naredi P
        • Iresjö BM.
        Expression of major histocompatibility complex class I-related chain A/B (MICA/B) in pancreatic carcinoma.
        Int J Oncol. 2014; 44: 99-104
        • Gasser S
        • Orsulic S
        • Brown EJ
        • Raulet DH.
        The DNA damage pathway regulates innate immune system ligands of the NKG2D receptor.
        Nature. 2005; 436: 1186-1190